OTLK (Outlook Therapeutics) Float Percentage Of Total Shares Outstanding: 90.85% (As of Jul. 05, 2026)


OTLK Outlook Therapeutics Inc OTLK
17 GF Score
Price $1.45
! 5 Warning Signs
View Full Analysis

What is Outlook Therapeutics Float Percentage Of Total Shares Outstanding?

Outlook Therapeutics OTLK -1.69% 17 Float Percentage Of Total Shares Outstanding is 90.85% as of Jul. 05, 2026. GuruFocus rates OTLK with a GF Score™ of 17/100. The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Outlook Therapeutics's float shares is 135.00 Mil. Outlook Therapeutics's total shares outstanding is 148.59 Mil. Outlook Therapeutics's float percentage of total shares outstanding is 90.85%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Outlook Therapeutics's Insider Ownership is 8.22%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Outlook Therapeutics's Institutional Ownership is 10.09%.

OTLK
17GF Score
Outlook Therapeutics Inc OTLK
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Outlook Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Outlook Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=135.00/148.59
=90.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 90.85% mean?
Outlook Therapeutics (OTLK) has a Float Percentage Of Total Shares Outstanding of 90.85% as of Jul. 05, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Outlook Therapeutics and its competitors.
Is Outlook Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Outlook Therapeutics' current Float Percentage Of Total Shares Outstanding is 90.85%. Overall, Outlook Therapeutics has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Outlook Therapeutics' Float Percentage Of Total Shares Outstanding compare to FULC and OBIO?
Outlook Therapeutics' Float Percentage Of Total Shares Outstanding of 90.85% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Outlook Therapeutics and its competitors. Outlook Therapeutics's current Float Percentage Of Total Shares Outstanding is 90.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Outlook Therapeutics stock overvalued right now?
Outlook Therapeutics (OTLK) has a current Float Percentage Of Total Shares Outstanding of 90.85%. The current Float Percentage Of Total Shares Outstanding is 90.85%. Outlook Therapeutics' overall GF Score™ is 17/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Outlook Therapeutics (OTLK), the current Float Percentage Of Total Shares Outstanding is 90.85% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Outlook Therapeutics Business Description

Other Exchanges 41O:Germany
Address 111 S. Wood Avenue, Suite 100, Iselin, NJ, USA, 08852
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
17GF Score

Get the complete analysis for OTLK

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.45
Price